Croda enters supply contract with Pfizer for COVID-19 vaccine excipients

Croda International entered into a five-year agreement with Pfizer to supply novel excipients used in the manufacture of a COVID-19 vaccine candidate, with an initial three-year supply contract for four component excipients.

“Croda International Plc, the speciality chemical company that uses smart science to create high-performance ingredients and technologies that improve lives, recently announced it has entered into an agreement with Pfizer Inc. to supply novel excipients used in the manufacture of a COVID-19 vaccine c”drug-dev.com

• 1 source
• drug-dev.comCroda Enters Contract With Pfizer for Innovative Delivery System for COVID-19 VaccineDan MarinoNov 11, 2020

Summarized from public sources; check the original articles before acting on it.